NJ Activists Plant Cannabis Garden On State House Lawn, Fentanyl Replaces MDMA In Fed Drug Testing, Psychedelics Therapy For Vets
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
NJ Activists Plant Cannabis Garden On State House Lawn, Fentanyl Replaces MDMA In Fed Drug Testing, Psychedelics Therapy For Vets
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
Psychedelic Productivity: Peer Pressure Or Good Career Advice?
Colorado Senate Approves Controversial Bill Restricting Social Media Posts On Substances Like Legal Hemp, Psychedelics
Psychedelic Productivity: Peer Pressure Or Good Career Advice?
Colorado Senate Approves Controversial Bill Restricting Social Media Posts On Substances Like Legal Hemp, Psychedelics
Veterans Affairs Is Not Preventing Suicides Successfully, Says GOP Rep. As Congressional Committee Approves Cannabis And Psychedelics Bills
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Psychedelics Recent News
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Podcast: Expert Talks About 'Kanna,' The Legal African Succulent That Elevates Awareness, Concentration And More
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Russell Newcombe Dies - Legacy Of UK's Longtime Harm Reduction Advocate, Committed Drug Researcher
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
